Cargando…
Reporting adverse events of ChAdOx1 nCoV-19 coronavirus vaccine (Recombinant) among the vaccinated healthcare professionals: A cross-sectional survey
BACKGROUND & OBJECTIVES: The safety of the ChAdOx1 nCoV-19 vaccine is a cause of concern for many who have been vaccinated. The people have multiple concerns and fear regarding the adverse events of the vaccine. Thus, this study was undertaken to establish the safety profile of ChAdOx1 nCoV-19 C...
Autores principales: | Kaur, Sukhpal, Singh, Ajay, Saini, Sushma, Rohilla, Latika, Kaur, Jasvir, Chandi, Anadeep, Kaur, Gurpreet, Singh, Manjeet, Kumar, Pramod, Soni, Shiv Lal, Kajal, Kamal, Naik, Naveen B., Malhotra, Pankaj, Verma, Sanjay, Gupta, Madhu, Devnani, Mahesh, Das, Karobi, Pandav, S.S., Puri, G.D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552383/ https://www.ncbi.nlm.nih.gov/pubmed/35859438 http://dx.doi.org/10.4103/ijmr.ijmr_1221_21 |
Ejemplares similares
-
Authors’ response
por: Kaur, Sukhpal, et al.
Publicado: (2022) -
Rapidly Progressive Dementia with Asymmetric Rigidity Following ChAdOx1 nCoV-19 Vaccination
por: Chakrabarti, Sankha Shubhra, et al.
Publicado: (2022) -
Lymphadenopathy subsequent to Covishield (ChAdOx1 nCoV-19) Corona
virus vaccine: ultrasound findings and clinical implications
por: Sahoo, Soumya Swaroop, et al.
Publicado: (2022) -
Determinants of COVID-19 Breakthrough Infections and Severity in ChAdOx1 nCoV-19–Vaccinated Priority Groups
por: Kaur, Upinder, et al.
Publicado: (2022) -
Thrombosis with Thrombocytopenia Syndrome (TTS) After ChAdOx1 nCoV-19 Immunization: An Investigative Case Report
por: Jain, Nityanand, et al.
Publicado: (2023)